Stent Leaders Pull Out Of India Amidst Price Cap Storm; Opportunity For 'The Dragon'?

The storm in India over price caps on stents has not shown any signs of abating, with foreign firms seeking to pull back certain key brands and the pricing regulator resolute about maintaining market equilibrium. The slugfest also appears to have opened up the Indian market for Chinese firms, among others.